Google Launches Deepmind 2 A Pharmaceutical Hullabaloo
In other words: The CEO of DeepMind, Demis Hassabis, is going to run a drug-discovery spinoff. Up front: This seems like a really good thing. DeepMind’s AlphaFold 2 has supposedly revolutionized how researchers study protein structures. And Hassabis is obviously pretty good at running a lab. But let’s just have a gander at the company’s blog, shall we? Here’s an interesting quote: I’m pretty sure most biologists and computer scientists would disagree with the assertion that a deep learning model could solve human biology....